Operational Policies
On this page you will find any clinical guidance and treatment pathways that have been approved by GMMMG or its Subgroups.
Documents are listed alphabetically.
The ‘Document Title’, ‘Issue Date’ and ‘Review Date’ headings below are active links. Click a heading to sort in ascending or descending order.
| Document Title | Issue Date | Review Date | Status |
|---|---|---|---|
| Engagement with the Pharmaceutical Industry | Dec 2017 | Dec 2020 | |
| GMMMG Appeals Policy | Dec 2017 | Dec 2020 | |
| GMMMG Declaration of interests - form | Sep 2016 | Sep 2019 | |
| GMMMG Declaration of interests - policy | Sep 2016 | Sep 2019 | |
| Guidelines for defining Red, Amber, Green, DNP and Grey status | Aug 2021 | ||
| High cost drug business case template | Oct 2013 | ||
| High cost drugs service development guideline | Oct 2013 | ||
| Management of Red Listed drugs in primary care | Apr 2019 | Apr 2022 | |
| Primary care rebate schemes |